4.13 Chapter Summary
4.13 Chapter Summary contains 3 topic pages in Phase 4 — Biological Activity Evaluation.
Topic Group
Topics
Continue through the related topic pages.
Frequently Asked Questions
Why must a selectivity index be reported alongside an anticancer IC50 value?
Common Interview and Viva Questions
Explain the difference between the DPPH and ORAC antioxidant assay principles.What does an MBC/MIC ratio of less than four indicate about an extract's...
Common Mistakes and Troubleshooting
A frequent methodological error is testing a crude extract at excessively high concentrations in a cell-based assay, producing non-specific cytotoxicity...